Recombinant human soluble thrombomodulin ameliorates cerebral ischemic injury through a high-mobility group box 1 inhibitory mechanism without hemorrhagic complications in mice - Nakamura, Y; Nakano, T; Irie, K (J Neurol Sci, 2016)
, et al.